Affordable Access

deepdyve-link
Publisher Website

CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.

Authors
  • Saintigny, Pierre
  • Massarelli, Erminia
  • Lin, Steven
  • Ahn, Young-Ho
  • Chen, Yulong
  • Goswami, Sangeeta
  • Erez, Baruch
  • O'Reilly, Michael S
  • Liu, Diane
  • Lee, J Jack
  • Zhang, Li
  • Ping, Yuan
  • Behrens, Carmen
  • Solis Soto, Luisa M
  • Heymach, John V
  • Kim, Edward S
  • Herbst, Roy S
  • Lippman, Scott M
  • Wistuba, Ignacio I
  • Hong, Waun Ki
  • And 2 more
Type
Published Article
Journal
Cancer Research
Publisher
American Association for Cancer Research
Publication Date
Jan 15, 2013
Volume
73
Issue
2
Pages
571–582
Identifiers
DOI: 10.1158/0008-5472.CAN-12-0263
PMID: 23204236
Source
Medline
License
Unknown

Abstract

CXCR2 in non-small cell lung cancer (NSCLC) has been studied mainly in stromal cells and is known to increase tumor inflammation and angiogenesis. Here, we examined the prognostic importance of CXCR2 in NSCLC and the role of CXCR2 and its ligands in lung cancer cells. The effect of CXCR2 expression on tumor cells was studied using stable knockdown clones derived from a murine KRAS/p53-mutant lung adenocarcinoma cell line with high metastatic potential and an orthotopic syngeneic mouse model and in vitro using a CXCR2 small-molecule antagonist (SB225002). CXCR2 protein expression was analyzed in tumor cells from 262 NSCLC. Gene expression profiles for CXCR2 and its ligands (CXCR2 axis) were analyzed in 52 human NSCLC cell lines and 442 human lung adenocarcinomas. Methylation of CXCR2 axis promoters was determined in 70 human NSCLC cell lines. Invasion and metastasis were decreased in CXCR2 knockdown clones in vitro and in vivo. SB225002 decreased invasion in vitro. In lung adenocarcinomas, CXCR2 expression in tumor cells was associated with smoking and poor prognosis. CXCR2 axis gene expression profiles in human NSCLC cell lines and lung adenocarcinomas defined a cluster driven by CXCL5 and associated with smoking, poor prognosis, and RAS pathway activation. Expression of CXCL5 was regulated by promoter methylation. The CXCR2 axis may be an important target in smoking-related lung adenocarcinoma.

Report this publication

Statistics

Seen <100 times